BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Urolithin%20B

urolithin B [Supplementary Concept] has antiproliferative activity; structure in first source Heading Mapped to: Coumarins All MeSH Categories urolithin B

52+ PubMed studies analyzed · 1 RCTs · Evidence Score: 35.6

Research Domains

Urolithin%20B has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, 🦠 Gut & Microbiome, 🧘 Stress & Anxiety, 🦴 Bone & Joint. The primary research focus is 🔬 Oncology with 39% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Urolithin%20B, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Tubercidin
4 shared targets
Chlormadinone
3 shared targets
Bufexamac
3 shared targets
Misoprostol
2 shared targets
lonidamine
3 shared targets
daph
2 shared targets
Bezafibrate
2 shared targets
Methylene
8 shared targets
Lanatosides
3 shared targets
Anisomycin
4 shared targets
Loading evidence profile...

This evidence profile for Urolithin%20B is generated deterministically from 52 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.